查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571832

微生物附着量测试市场规模、份额和趋势分析报告：2024-2030 年按产品、测试、应用、最终用途、地区和细分市场进行的预测

Bioburden Testing Market Size, Share & Trends Analysis Report By Product (Consumables, Instruments), By Test, By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

微生物附着量测试市场成长与趋势：

根据Grand View Research, Inc.最新报告，到2030年，全球微生物附着量测试市场规模预计将达到32.2亿美元，预测期内复合年增长率为14.3%。

由于对产品安全的担忧日益加剧，预计未来几年市场将呈现扩大趋势。因此，政府正在采取各种措施来推广微生物安全测试工具。

各组织为提高人们对微生物安全测试的认识而出版的许多出版物正在扩大微生物附着量测试未来成长的前景。例如，美国卫生与公众服务部和疾病管制中心製定了《医学实验室微生物学和生物生物安全（BMBL）》并出版。

製药、生物技术、医疗设备以及食品和饮料行业的成长推动了微生物附着量测试市场的快速成长。此外，知名公司增加的研发投资预计将鼓励最终用户采用高效的微生物附着量测试工具，以应对微生物污染造成的损失。此外，临床前研究对基本药物安全资料的需求预计将推动对微生物附着量测试工具的需求。

微生物附着量测试市场报告亮点

  • 从产品来看，由于培养基、试剂和套件的广泛使用，消耗品领域在 2023 年占据市场主导地位。
  • PCR 仪器有助于快速分析细菌微生物附着量，进而推动市场快速成长。
  • 由于使用培养基可以轻鬆分离需气菌需气菌计数检测在 2023 年占据最大的市场占有率。
  • 由于产品召回的增加和对产品品质的担忧，预计原材料检验在预测期内将出现良好的增长。
  • 从最终用途来看，由于该行业的高速成长，製药和生物技术公司将在 2023 年主导市场。
  • CMO数量大幅增加，导致外包服务增加。
  • 由于主要企业的研发费用较高以及美国的医疗保健支出较高，北美地区在 2023 年占据了最大的收益占有率。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章微生物附着量测试市场变数、趋势、范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 微生物附着量测试市场分析工具
    • 波特的分析
    • PESTEL分析

第四章微生物附着量测试市场：产品估算与趋势分析

  • 细分仪表板
  • 微生物附着量测试市场：2023 年和 2030 年产品变化分析
  • 消耗品
  • 装置

第五章微生物附着量测试市场：测试估算与趋势分析

  • 细分仪表板
  • 微生物附着量测试市场：2023 年和 2030 年测试变异分析
  • 有氧计数测试
  • 厌氧计数测试
  • 真菌/霉菌计数测试
  • 孢子计数测试

第六章微生物附着量测试市场：应用估算与趋势分析

  • 细分仪表板
  • 微生物附着量测试市场：2023 年和 2030 年应用变化分析
  • 原料检测
  • 医疗设备测试
  • 进程内材料测试
  • 灭菌检验试验
  • 设备清洗检验

第七章微生物附着量测试市场：最终用途估计与趋势分析

  • 细分仪表板
  • 微生物附着量测试市场：最终用途变化分析，2023 年和 2030 年
  • 製药和生物技术公司
  • 医疗设备製造商
  • 契约製造组织
  • 食品/饮料/农产品製造商
  • 微生物检测实验室

第八章微生物附着量测试市场：区域估计和趋势分析

  • 2023 年和 2030 年微生物附着量测试市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 科威特

第9章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Charles River Laboratories
    • Merck KGaA
    • SGS Societe Generale de Surveillance SA.
    • WuXi AppTec
    • BD
    • North American Science Associates, LLC
    • Nelson Laboratories, LLC
    • Thermo Fisher Scientific Inc
    • BIOMERIEUX
    • Pacific Biolabs
简介目录
Product Code: GVR-3-68038-774-2

Bioburden Testing Market Growth & Trends:

The global bioburden testing market size is expected to reach USD 3.22 billion by 2030, registering a CAGR of 14.3% during the forecast period, according to a new report by Grand View Research, Inc. The market is expected to showcase upward trend in the forthcoming years owing to growing concerns about product safety. This has led to various government initiatives to promote microbiological safety testing tools.

A number of publications released by organizations to promote awareness regarding microbiological safety testing is broadening the future growth prospects of bioburden testing. For instance, the U.S. Department of Health and Human Services and Centers for Disease Control published Biosafety in Microbiological and Biomedical Laboratories (BMBL), which includes information pertaining to laboratory biosecurity and risk assessment, decontamination and sterilization, and biological toxins and biosafety levels in laboratories.

Growth of pharmaceutical, biotechnology, medical device, and food and beverage industries have contributed to the high growth of the bioburden testing market. In addition, increase in R&D investments by prominent companies is expected to encourage end users to adopt highly efficient bioburden testing tools to counter possible losses due to microbial contamination. Moreover, requirement for basic drug safety data requirements for preclinical studies is expected to fuel the demand for bioburden testing tools.

Bioburden Testing Market Report Highlights:

  • On the basis of product, consumables segment dominated the market in 2023 owing to a wide use of culture media and reagents and kits.
  • The PCR instruments facilitate rapid analysis of bacterial bioburden, thus, fostering high market growth.
  • The aerobic count-testing held largest market share in 2023 due to easy isolation of aerobic bacteria by culture media.
  • Raw material testing is anticipated to showcase lucrative growth during the forecast period owing to the increasing number of product recalls and concern regarding product quality.
  • On the basis of end-use, pharmaceutical and biotechnology companies dominated the market in 2023 owing to the high growth of this industry.
  • The number of CMOs is increasing significantly, which has led to a rise in outsourcing services, thus, driving the segment growth.
  • North America held the largest revenue share in 2023 due to high R&D spending by key companies and high healthcare spending in the U.S.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Bioburden Testing Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Billion)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Bioburden Testing Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Bioburden Testing Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Bioburden Testing Market: Product Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Consumables
    • 4.3.1. Consumables Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.1. Culture Media
        • 4.3.1.1.1. Culture Media Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.3.1.2. Reagents and Kits
        • 4.3.1.2.1. Reagents and Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Instruments
    • 4.4.1. Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.1. Automated Microbial Identification Systems
        • 4.4.1.1.1. Automated Microbial Identification Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 4.4.1.2. PCR Instruments
        • 4.4.1.2.1. PCR Instruments Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Bioburden Testing Market: Test Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Bioburden Testing Market: Test Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Aerobic Count Testing
    • 5.3.1. Aerobic Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Anaerobic Count Testing
    • 5.4.1. Anaerobic Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Fungi/Mold Count Testing
    • 5.5.1. Fungi/Mold Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Spore Count Testing
    • 5.6.1. Spore Count Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Bioburden Testing Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Bioburden Testing Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Raw Material Testing
    • 6.3.1. Raw Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Medical Device Testing
    • 6.4.1. Medical Device Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. In-Process Material Testing
    • 6.5.1. In-Process Material Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Sterilization Validation Testing
    • 6.6.1. Sterilization Validation Testing Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Equipment Cleaning Validation
    • 6.7.1. Equipment Cleaning Validation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Bioburden Testing Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Bioburden Testing Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 7.3. Pharmaceutical & Biotechnology Companies
    • 7.3.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Medical Device Manufacturers
    • 7.4.1. Medical Device Manufacturers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Contract Manufacturing Organizations
    • 7.5.1. Contract Manufacturing Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Manufacturers of Food & Beverage and Agricultural Products
    • 7.6.1. Manufacturers of Food & Beverage and Agricultural Products Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7. Microbial Testing Laboratories
    • 7.7.1. Microbial Testing Laboratories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Bioburden Testing Market: Regional Estimates & Trend Analysis

  • 8.1. Bioburden Testing Market Share, By Region, 2023 & 2030 (USD Million)
  • 8.2. North America
    • 8.2.1. North America Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.2. U.S.
      • 8.2.2.1. U.S. Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.3. Canada
      • 8.2.3.1. Canada Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.2.4. Mexico
      • 8.2.4.1. Mexico Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3. Europe
    • 8.3.1. Europe Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.2. UK
      • 8.3.2.1. UK Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.3. Germany
      • 8.3.3.1. Germany Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.4. France
      • 8.3.4.1. France Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.5. Italy
      • 8.3.5.1. Italy Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.6. Spain
      • 8.3.6.1. Spain Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.7. Denmark
      • 8.3.7.1. Denmark Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.8. Sweden
      • 8.3.8.1. Sweden Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.3.9. Norway
      • 8.3.9.1. Norway Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4. Asia Pacific
    • 8.4.1. Asia Pacific Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.2. China
      • 8.4.2.1. China Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Japan
      • 8.4.3.1. Japan Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. India
      • 8.4.4.1. India Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.5. South Korea
      • 8.4.5.1. South Korea Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.6. Australia
      • 8.4.6.1. Australia Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.4.7. Thailand
      • 8.4.7.1. Thailand Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Latin America
    • 8.5.1. Latin America Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.2. Brazil
      • 8.5.2.1. Brazil Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Argentina
      • 8.5.3.1. Argentina Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Middle East and Africa
    • 8.6.1. Middle East and Africa Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.2. Saudi Arabia
      • 8.6.2.1. Saudi Arabia Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. UAE
      • 8.6.3.1. UAE Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. South Africa
      • 8.6.4.1. South Africa Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. Kuwait
      • 8.6.5.1. Kuwait Bioburden Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Heat Map Analysis
  • 9.4. Company Profiles
    • 9.4.1. Charles River Laboratories
      • 9.4.1.1. Participant's Overview
      • 9.4.1.2. Financial Performance
      • 9.4.1.3. Product Benchmarking
      • 9.4.1.4. Recent Developments/ Strategic Initiatives
    • 9.4.2. Merck KGaA
      • 9.4.2.1. Participant's Overview
      • 9.4.2.2. Financial Performance
      • 9.4.2.3. Product Benchmarking
      • 9.4.2.4. Recent Developments/ Strategic Initiatives
    • 9.4.3. SGS Societe Generale de Surveillance SA.
      • 9.4.3.1. Participant's Overview
      • 9.4.3.2. Financial Performance
      • 9.4.3.3. Product Benchmarking
      • 9.4.3.4. Recent Developments/ Strategic Initiatives
    • 9.4.4. WuXi AppTec
      • 9.4.4.1. Participant's Overview
      • 9.4.4.2. Financial Performance
      • 9.4.4.3. Product Benchmarking
      • 9.4.4.4. Recent Developments/ Strategic Initiatives
    • 9.4.5. BD
      • 9.4.5.1. Participant's Overview
      • 9.4.5.2. Financial Performance
      • 9.4.5.3. Product Benchmarking
      • 9.4.5.4. Recent Developments/ Strategic Initiatives
    • 9.4.6. North American Science Associates, LLC
      • 9.4.6.1. Participant's Overview
      • 9.4.6.2. Financial Performance
      • 9.4.6.3. Product Benchmarking
      • 9.4.6.4. Recent Developments/ Strategic Initiatives
    • 9.4.7. Nelson Laboratories, LLC
      • 9.4.7.1. Participant's Overview
      • 9.4.7.2. Financial Performance
      • 9.4.7.3. Product Benchmarking
      • 9.4.7.4. Recent Developments/ Strategic Initiatives
    • 9.4.8. Thermo Fisher Scientific Inc
      • 9.4.8.1. Participant's Overview
      • 9.4.8.2. Financial Performance
      • 9.4.8.3. Product Benchmarking
      • 9.4.8.4. Recent Developments/ Strategic Initiatives
    • 9.4.9. BIOMERIEUX
      • 9.4.9.1. Participant's Overview
      • 9.4.9.2. Financial Performance
      • 9.4.9.3. Product Benchmarking
      • 9.4.9.4. Recent Developments/ Strategic Initiatives
    • 9.4.10. Pacific Biolabs
      • 9.4.10.1. Participant's Overview
      • 9.4.10.2. Financial Performance
      • 9.4.10.3. Product Benchmarking
      • 9.4.10.4. Recent Developments/ Strategic Initiatives